col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


78 Ergebisse       Seite 1

 [1] 
Wiley: Liver International
  Original Artikel Datum Titel Autoren   Max. 6 Autoren
1 [GO] 2023―Dez―19 NAFLD and NASH are obesity-independent risk factors in COVID-19: Matched real-world results from the large PINC AI™ Healthcare Database Jonathan F. Brozat, Fady Ntanios, Deepa Malhotra, Simon Dagenais, Nino Katchiuri, Birol Emir, Frank Tacke
2 [GO] 2023―Sep―22 Forecasting the long-term impact of COVID-19 on hepatitis C elimination plans in Italy: A mathematical modelling approach Loreta A. Kondili, Massimo Andreoni, Alessio Aghemo, Claudio Maria Mastroianni, Rocco Merolla, Valentina Gallinaro, Gianpiero D'Offizi, Antonio Craxì
3 [GO] 2023―Sep―22 Ursodeoxycholic acid does not affect the clinical outcome of SARS-CoV-2 infection: A retrospective study of propensity score-matched cohorts Giuseppe Marrone, Marcello Covino, Giuseppe Merra, Andrea Piccioni, Annamaria Amodeo, Angela Novelli, Rita Murri, Maurizio Pompili, Antonio Gasbarrini, Francesco Franceschi
4 [GO] 2023―Jun―30 Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021 Donghee Kim, Richie Manikat, George Cholankeril, Aijaz Ahmed
5 [GO] 2023―Jun―29 Ursodeoxycholic acid administration did not reduce susceptibility to SARS-CoV-2 infection in children Teng Liu, Jian-She Wang
6 [GO] 2023―Mrz―17 Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients Marzia Montalbano, Paola Piccolo, Raffaella Lionetti, Ubaldo Visco-Comandini, Chiara Agrati, Germana Grassi, Silvia Meschi, Giulia Matusali, Federica Conte, Federica Angelone, Giuseppe Maria Ettorre, Nicola Guglielmo, Fabrizio Maggi, Massimo Francalancia, Tiziana Mereu, Vincenzo Puro, Enrico Girardi, Gianpiero D’Offizi
7 [GO] 2022―Sep―06 No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in Milan Masetti Chiara, Colapietro Francesca, Voza Antonio, Aghemo Alessio
8 [GO] 2022―Aug―25 No impact of Covid-19 epidemic on decompensation of alcoholic liver disease: results from a single-center in Milan Masetti Chiara, Colapietro Francesca, Voza Antonio, Aghemo Alessio
9 [GO] 2022―Aug―20 Immunogenicity of COVID-19 vaccines in chronic liver disease patients and liver transplant recipients: a systematic review and meta-analysis De Luo, Xinpei Chen, Juan Du, Bingjie Mei, Ankang Wang, Fei Kuang, Cheng Fang, Yu Gan, Fangyi Peng, Xiaoli Yang, Uta Dahmen, Bo Li, Su Song
10 [GO] 2022―Jul―23 HCV point of care screening in people tested for SARS-CoV -2 in a social-housing neighbourhood of Milan, Italy Martina Beltrami, Gabriele Pagani, Federico Conti, Laura Pezzati, Giacomo Casalini, Rossana Rondanin, Andrea Prina, Antonino Zagari, Massimo Galli, Andrea Giacomelli
11 [GO] 2022―Jul―20 Third Dose of mRNA COVID-19 Vaccine and response: Correspondence Pathum Sookaromdee, Viroj Wiwanitkit
12 [GO] 2022―Jun―28 Autoimmune hepatitis (AIH) following coronavirus (COVID-19) vaccine - no longer exclusive to mRNA vaccine? Shahreedhan Shahrani, Sooi Choong Yeong, Ida Normiha Hilmi, Sanjiv Mahadeva
13 [GO] 2022―Jun―09 Mycophenolate and SARS-CoV -2 vaccination: Mixing oil and water Marisol Arenas-De Larriva, Manuel L. Rodríguez-Perálvarez
14 [GO] 2022―Jun―09 Sars-Cov -2 vaccination in liver transplant recipients: The ‘holy grail’ in a hostile environment Patrizia Burra, Francesco Paolo Russo
15 [GO] 2022―Jun―07 Response to: “No Impact of Covid-19 Pandemic on Decompensation of Alcoholic Liver Disease: Results from a Single Center in Milan” Humberto C. Gonzalez, Loralee B. Rupp, Sheri Trudeau, Stuart C. Gordon
16 [GO] 2022―Mai―28 Screening for hepatitis C at the time of the pandemic: Need to adjust the shot Pietro Torre, Carmine Coppola, Mario Masarone, Marcello Persico
17 [GO] 2022―Mai―24 Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jordi Bruix, Marco Sanduzzi-Zamparelli, José Ríos, Mohamed Bouattour, Mohamed El-Kassas, Cassia R. G. Leal, Tudor Mocan, Jean-Charles Nault, Rogerio C. P. Alves, Helen L. Reeves, Leonardo da Fonseca, Ignacio García-Juárez, David J. Pinato, María Varela, Saleh A. Alqahtani, Mario R. Alvares-da-Silva, Juan C. Bandi, Lorenza Rimassa, Mar Lozano, Jesús M. González Santiago, Frank Tacke, Margarita Sala, María Anders, Anja Lachenmayer, Federico Piñero, Alex França, Maria Guarino, Alessandra Elvevi, Giuseppe Cabibbo, Markus Peck-Radosavljevic, Ángela Rojas, Mercedes Vergara, Chiara Braconi, Sonia Pascual, Christie Perelló, Vivianne Mello, Carlos Rodríguez-Lope, Juan Acevedo, Rosanna Villani, Clemence Hollande, Valérie Vilgrain, Ahmed Tawheed, Carmem Ferguson Theodoro, Zeno Sparchez, Lorraine Blaise, Daniele E. Viera-Alves, Robyn Watson, Flair J. Carrilho, Carlos Moctezuma-Velázquez, Antonio D'Alessio, Massimo Iavarone, Maria Reig
18 [GO] 2022―Apr―08 Hepatitis C screening during SARS-CoV -2 testing or vaccination. Experience in an area of Southern Italy in the province of Salerno Pietro Torre, Monica Annunziata, Roberta Sciorio, Carmine Coppola, Mario Masarone, Marcello Persico
19 [GO] 2022―Mrz―28 Quality of life in liver transplant recipients during the Corona Virus Disease 19 pandemic: a multicenter study Stefano Gitto, Lucia Golfieri, Nicolò Mannelli, Maria Rosa Tamè, Ivo Lopez, Roberta Ceccato, Stanislao Montanari, Margherita Falcini, Giovanni Vitale, Nicola Maria, Danilo Lo Presti, Luca Marzi, Andrea Mega, Giovanna Valente, Alberto Borghi, Francesco Giuseppe Foschi, Silvana Grandi, Paolo Forte, Matteo Cescon, Fabrizio Di Benedetto, Pietro Andreone, Giulio Arcangeli, Paolo De Simone, Andrea Bonacchi, Francesco Sofi, Maria Cristina Morelli, Marco Petranelli, Chloe Lau, Fabio Marra, Francesca Chiesi, Francesco Vizzutti, Vittoria Vero, Roberto Di Donato, Sonia Berardi, Paolo Pianta, Sharon D’Anzi, Filippo Schepis, Noemi Gualandi, Francesca Miceli, Erica Villa, Guido Piai, Marco Valente, Claudia Campani, Erica Lynch, Paolo Magistri, Carmela Cursaro, Anna Chiarelli, Paola Carrai, Stefania Petruccelli, Monica Dinu, Giuditta Pagliai
20 [GO] 2022―Mrz―26 Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV -2 vaccine in liver transplant recipients Lucy Meunier, Mathilde Sanavio, Jérôme Dumortier, Magdalena Meszaros, Stéphanie Faure, José Ursic Beodya, Maxime Echenne, Olivier Boillot, Antoine Debourdeau, Georges Philippe Pageaux
21 [GO] 2022―Feb―23 Nintedanib induced liver injury: Not every liver injury is virus or vaccine-induced in the era of COVID-19 Anuraag Jena, Tanushi Aggarwal, Suvradeep Mitra, Anupam Kumar Singh
22 [GO] 2022―Feb―07 Vaccination against COVID-19 decreases hospitalizations in patients with cirrhosis: Results from a nationwide analysis Luis Antonio Díaz, Eduardo Fuentes-López, Mariana Lazo, Patrick S. Kamath, Marco Arrese, Juan Pablo Arab
23 [GO] 2022―Feb―02 Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection Taiyu He, Yingzhi Zhou, Pan Xu, Ning Ling, Min Chen, Tianquan Huang, Biqiong Zhang, Ziqiao Yang, Ling Ao, Hu Li, Zhiwei Chen, Dazhi Zhang, Xiaofeng Shi, Yu Lei, Zhiyi Wang, Weiqun Zeng, Peng Hu, Yinghua Lan, Zhi Zhou, Juan Kang, Ying Huang, Tongdong Shi, Qingbo Pan, Qian Zhu, Xiping Ran, Yingzhi Zhang, Rui Song, Dejuan Xiang, Shuang Xiao, Gaoli Zhang, Wei Shen, Mingli Peng, Dachuan Cai, Hong Ren
24 [GO] 2022―Jan―30 Alcohol-related hepatitis admissions increased 50% in the first months of the CoViD -19 pandemic in the US Humberto C Gonzalez, Yueren Zhou, Faisal M Nimri, Loralee B Rupp, Sheri Trudeau, Stuart C Gordon
25 [GO] 2022―Jan―29 Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19? Benedetta Terziroli Beretta-Piccoli, Ana Lleo
26 [GO] 2022―Jan―07 Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction-associated fatty liver disease Hideki Fujii, Naotoshi Nakamura, Shinya Fukumoto, Tatsuo Kimura, Akemi Nakano, Yuji Nadatani, Yukie Tauchi, Yuuko Nishii, Shingo Takashima, Yoshihiro Kamada, Toshio Watanabe, Norifumi Kawada
27 [GO] 2021―Dez―16 Is it time to get rid of the biopsy mandate in adults with suspected Autoimmune hepatitis? Lessons from the COVID-19 pandemic. Ali Ibrahim Shorbagi
28 [GO] 2021―Nov―30 Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis Cumali Efe, Craig Lammert, Koray Taşçılar, Renumathy Dhanasekaran, Berat Ebik, Fatima Higuera-de la Tijera, Ali Rıza Calışkan, Mirta Peralta, Alessio Gerussi, Hatef Massoumi, Andreea M. Catana, Tugrul Purnak, Cristina Rigamonti, Andres Jose Gomez Aldana, Nidah Khakoo, Leyla Nazal, Shalom Frager, Nurhan Demir, Kader Irak, Zeynep Melekoğlu Ellik, Hüseyin Kacmaz, Yasemin Balaban, Kadri Atay, Fatih Eren, Mario Reis Alvares-da-Silva, Laura Cristoferi, Álvaro Urzua, Tuğçe Eşkazan, Bianca Magro, Romee Snijders, Sezgin Barutçu, Ellina Lytvyak, Godolfino Miranda Zazueta, Aylin Demirezer Bolat, Mesut Aydın, Alexandra Heurgue-Berlot, Eleonora De Martin, Nazım Ekin, Sümeyra Yıldırım, Ahmet Yavuz, Murat Bıyık, Graciela Castro Narro, Murat Kıyıcı, Murat Akyıldız, Evrim Kahramanoğlu-Aksoy, Maria Vincent, Rotonya M Carr, Fulya Günşar, Eira Cerda Reyes, Murat Harputoğlu, Costica Aloman, Nikolaos K. Gatselis, Yücel Üstündağ, Javier Brahm, Nataly Chris Escajadillo Vargas, Fatih Güzelbulut, Sandro Ruiz Garcia, Jonathan Aguirre, Margarita Anders, Natalia Ratusnu, Ibrahim Hatemi, Manuel Mendizabal, Annarosa Floreani, Stefano Fagiuoli, Marcelo Silva, Ramazan Idilman, Sanjaya K. Satapathy, Marina Silveira, Joost P. H. Drenth, George N Dalekos, David N. Assis, Einar Björnsson, James L. Boyer, Eric M. Yoshida, Pietro Invernizzi, Cynthia Levy, Aldo J. Montano-Loza, Thomas D. Schiano, Ezequiel Ridruejo, Staffan Wahlin
29 [GO] 2021―Nov―01 A typical autoimmune hepatitis (AIH) case following Covid-19 mRNA vaccination. More than a coincidence? Anestis Goulas, Georgia Kafiri, Hariklia Kranidioti, Spilios Manolakopoulos
30 [GO] 2021―Okt―31 Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients Gianpiero D’Offizi, Chiara Agrati, Ubaldo Visco-Comandini, Concetta Castilletti, Vincenzo Puro, Paola Piccolo, Montalbano Marzia, Silvia Meschi, Eleonora Tartaglia, Chiara Sorace, Sara Leone, Daniele Lapa, Germana Grassi, Delia Goletti, Giuseppe Ippolito, Francesco Vaia, Giuseppe Maria Ettorre, Raffaella Lionetti
31 [GO] 2021―Okt―08 Reshape and secure HCC managing during COVID-19 pandemic: a single center analysis of four periods in 2020 versus 2019 Massimo Iavarone, Barbara Antonelli, Anna Maria Ierardi, Matilde Topa, Angelo Sangiovanni, Andrea Gori, Chiara Oggioni, Giorgio Rossi, Gianpaolo Carrafiello, Pietro Lampertico
32 [GO] 2021―Okt―07 Aspartate aminotransferase in COVID-19: A probably overrated marker Elena Aloisio, Mauro Panteghini, Luca Valenti
33 [GO] 2021―Sep―30 Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: an interrupted time series analysis Mawuena Binka, Sofia Bartlett, Héctor Alexander Velásquez García, Maryam Darvishian, Dahn Jeong, Prince Adu, Maria Alvarez, Stanley Wong, Amanda Yu, Hasina Samji, Mel Krajden, Jason Wong, Naveed Zafar Janjua
34 [GO] 2021―Sep―23 COVID-19, adaptative immune response and metabolic associated liver disease Luca Miele, Cecilia Napodano, Alfredo Cesario, Antonio De Magistris, Krizia Pocino, Umberto Basile, Gian Ludovico Rapaccini, Antonio Gasbarrini, Antonio Grieco
35 [GO] 2021―Sep―03 Autoimmune hepatitis triggered by COVID-19: A report of two cases Gökhan Kabaçam, Staffan Wahlin, Cumali Efe
36 [GO] 2021―Aug―29 PNPLA3 and COVID-19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system Carlos J Pirola, Silvia Sookoian
37 [GO] 2021―Jul―05 Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: a web-based survey Francesca Romana Ponziani, Alessio Aghemo, Giuseppe Cabibbo, Mario Masarone, Sara Montagnese, Salvatore Petta, Francesco Paolo Russo, Quirino Lai, Maria Oliva Pensi, Marta Tonon, Daniela Campion, Tommaso Maria Manzia, Renato Finazzi, Giorgio Soardo, Stefano Fagiuoli, Ana Lleo, Lorenzo Nosotti, Ludovico Abenavoli, Salvatore D'Angelo, Sara Montagnese, Maria Rendina, Patrizia Cocco, Simona Francioso, Paolo Caraceni, Silvia Martini, Raffaele Cozzolongo, Giovan Giuseppe Di Costanzo, Salvatore Stefano Sciarrone, Marcello Bianchini, Paola Piccolo, Pietro Andreone, Antonio Liguori, Silvia Gaia, Mauro Sapienza, Mariarosa Tamè, Mariagrazia Rumi, Luchino Chessa, Vito Sansone, Gabriella Verucchi, Enrico Gringeri, Giuseppina Renier, Rachele Rapetti, Monica Cucco, Edoardo Giovanni Giannini, Carlo Saitta, Ludovico Abenavoli, Ubaldo Visco Comandini, Anna Fracanzani, Angelo Salomone Megna, Maria Teresa Falce, Irene Franceschet, Natalia Terreni, Chiara Ferrara, Michele Campigotto, Simona Parisse, Giulia Morsica, Monica Moretti, Adriana Giorgi, Nadia Trancanella, Stefano Abbruzzese, Dario D’Agostino
38 [GO] 2021―Jun―22 COVID-19 and the liver - Lessons learned Toni Herta, Thomas Berg
39 [GO] 2021―Jun―21 COVID-19 And The Liver: a 2021 Update CW Spearman, A Aghemo, L Valenti, MW Sonderup
40 [GO] 2021―Jun―01 Hepatitis C Elimination in Sweden: Progress, Challenges and Opportunities for Growth in the time of COVID-19 S Blach, M Blomé, A-S Duberg, A Jerkeman, M Kåberg, P-E Klasa, M Lagging, D Razavi-Shearer, H Razavi, S Aleman
41 [GO] 2021―Mai―21 Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19 Simon Bütikofer, Daniela Lenggenhager, Pedro David Wendel Garcia, Ewerton Marques Maggio, Martina Haberecker, Cäcilia S. Reiner, Gregor Brüllmann, Karl Philipp Bühler, Christoph Gubler, Beat Müllhaupt, Christoph Jüngst, Bernhard Morell
42 [GO] 2021―Apr―07 Liver involvement in Children with SARS-COV-2 Infection: Two Distinct Clinical Phenotypes Caused by the Same Virus Adriana Pere, Amanda Cantor, Bryan Rudolph, Jonathan Miller, Debora Kogan-Liberman, Qi Gao, Bernardo Da Silva, Kara Gross Margolis, Nadia Ovchinsky, Mercedes Martinez
43 [GO] 2021―Feb―05 Mortality is Not Increased in SARS-CoV-2 Infected Persons With Hepatitis C Virus Infection Adeel A. Butt, Peng Yan, Rashid A. Chotani, Obaid S. Shaikh
44 [GO] 2020―Dez―23 Clinical Characteristics of COVID-19 Patients with Hepatitis B Virus Infection - a Retrospective Study Rui Liu, Li Zhao, Xiaoming Cheng, Han Huan, Cong Li, Dong Li, Andrew Liu, Guosheng Gao, Feng Zhou, Fang Liu, Yingan Jiang, Chengliang Zhu, Yuchen Xia
45 [GO] 2020―Nov―17 Genetic insight into COVID-19 related liver injury: a note on MBOAT7 Antonia Machill, Robert Bals, Frank Lammert, Marcin Krawczyk
46 [GO] 2020―Nov―15 Pathophysiological mechanisms of liver injury in COVID-19 Alexander D. Nardo, Mathias Schneeweiss-Gleixner, May Bakail, Emmanuel D. Dixon, Sigurd F. Lax, Michael Trauner
47 [GO] 2020―Nov―07 COVID-19 and liver disease: not all evil comes to harm Elisa Marabotto, Sebastiano Ziola, Afscin Djahandideh Sheijani, Edoardo G. Giannini
48 [GO] 2020―Okt―24 Genetic insight into Covid-19 related liver injury Cristiana Bianco, Guido Baselli, Francesco Malvestiti, Luigi Santoro, Serena Pelusi, Maria Manunta, Giacomo Grasselli, Alessandra Bandera, Luigia Scudeller, Daniele Prati, Luca Valenti
49 [GO] 2020―Okt―02 Rates and Characteristics of SARS-CoV-2 Infection in Persons with Hepatitis C Virus Infection Adeel A. Butt, Peng Yan
50 [GO] 2020―Jul―17 Value-based medicine, a compass to guide health care decisions in the COVID-19 aftermath Mario Strazzabosco
51 [GO] 2020―Jul―17 Running out of bullets: the challenging management of acute hepatitis and SARS-COV-2 from the SMatteo COvid19 Registry (SMACORE) Marta Colaneri, Pietro Valsecchi, Luciano Perotti, Serena Ludovisi, Elena Seminari, Teresa Chiara Pieri, Paolo Sacchi, Raffaele Bruno
52 [GO] 2020―Jun―25 Impact of Chronic Liver Disease on Outcomes of Hospitalized Patients with COVID-19: A Multicenter United States Experience Nikroo Hashemi, Kathleen Viveiros, Walker D. Redd, Joyce C. Zhou, Thomas R. McCarty, Ahmad Najdat Bazarbashi, Kelly E. Hathorn, Danny Wong, Cheikh Njie, Lin Shen, Walter W. Chan
53 [GO] 2020―Jun―23 Metabolic associated fatty liver disease is associated with severity of COVID-19 Yu-Jie Zhou, Kenneth I. Zheng, Xiao-Bo Wang, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, Hong-Lei Ma, Yong-Ping Chen, Jacob George, Ming-Hua Zheng
54 [GO] 2020―Jun―19 Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng
55 [GO] 2020―Jun―11 Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 Salvatore Piano, Andrea Dalbeni, Elia Vettore, Devis Benfaremo, Massimo Mattioli, Carmine Gabriele Gambino, Viviana Framba, Lorenzo Cerruti, Anna Mantovani, Andrea Martini, Michele Maria Luchetti, Roberto Serra, Annamaria Cattelan, Roberto Vettor, Paolo Angeli, Gaetano Arcidiacono, Silvia Bettini, Benedetta Maria Bonora, Giovanni Bucca, Armando Gabrielli, Francesca Ghirardini, Umberto Gnudi, Sara Mareso, Marco Marini, Luciano Mucci, Gian Piero Perna, Fabio Presotto, Caterina Sensi, Francesco Soliani, Roberta Stupia, Mirko Zoncapè
56 [GO] 2020―Jun―11 A letter of solidarity during the COVID-19 Pandemic Jeffrey V. Lazarus, Francesco Negro, Manal El-Sayed, Massimo Colombo
57 [GO] 2020―Jun―04 Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry? Magdalena Meszaros, Lucy Meunier, David Morquin, Kada Klouche, Pierre Fesler, Emilie Malezieux, Alain Makinson, Vincent le Moing, Jacques Reynes, Georges-Philippe Pageaux
58 [GO] 2020―Mai―29 Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience Anita Verma, Shirin Elizabeth Khorsandi, Annalisa Dolcet, Andreas Prachalias, Abid Suddle, Nigel Heaton, Wayel Jassem
59 [GO] 2020―Mai―23 Can thrombotic events be a major concern in hepatocellular carcinoma patients under systemic treatment during SARS-Cov-2? Leonardo da Fonseca, Flair José Carrilho
60 [GO] 2020―Mai―21 SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure Karsten Große, Matthijs Kramer, Christian Trautwein, Tony Bruns
61 [GO] 2020―Mai―20 COVID-19 and liver cancer clinical trials: not everything is lost Antonio D’Alessio, Nicola Personeni, Tiziana Pressiani, Silvia Bozzarelli, Valeria Smiroldo, Matteo Simonelli, Ana Lleo, Armando Santoro, Lorenza Rimassa
62 [GO] 2020―Mai―17 First case of drug-induced liver injury (DILI) associated with the use of tocilizumab in a patient with COVID-19 Damir Muhović, Jelena Bojović, Ana Bulatović, Batrić Vukčević, Marina Ratković, Ranko Lazović, Brigita Smolović
63 [GO] 2020―Mai―16 Management of Hepatocellular Cancer in the time of SARS-CoV-2 Rohini Sharma, David J. Pinato
64 [GO] 2020―Mai―11 Liver injury in COVID-19: diagnosis and associated factors - authors' reply Ningfang Lian, Su Lin, Hansheng Xie
65 [GO] 2020―Mai―05 Acute on Chronic Liver Failure from Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) He Qiu, Praneet Wander, David Bernstein, Sanjaya K. Satapathy
66 [GO] 2020―Mai―02 Liver injury in COVID-19: diagnosis and associated factors Zheng Ye, Bin Song
67 [GO] 2020―Apr―30 SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19 Carlos J Pirola, Silvia Sookoian
68 [GO] 2020―Apr―29 Author response to Letter to the Editor “Liver impairment associated with disease progression in COVID-19 patients” Yafei Zhang, Lan Liu, Qiu Zhao
69 [GO] 2020―Apr―22 COVID-19 and viral hepatitis elimination programs: Are we stepping backward? Hamidreza Karimi-Sari, Mohammad Saeid Rezaee-Zavareh
70 [GO] 2020―Apr―19 Potential implications of COVID-19 in non-alcoholic fatty liver disease Grietje H. Prins, Peter Olinga
71 [GO] 2020―Apr―18 Bilirubin levels in patients with mild and severe Covid-19: a pooled analysis Panagiotis Paliogiannis, Angelo Zinellu
72 [GO] 2020―Apr―15 Liver impairment associated with disease progression in COVID-19 patients Peng Chen, Jiexin Lei, Yue Wu, Gang Liu, Benhong Zhou
73 [GO] 2020―Apr―06 COVID-19 and liver disease Jian Sun, Alessio Aghemo, Alejandro Forner, Luca Valenti
74 [GO] 2020―Apr―05 Coronavirus disease 2019 (COVID-19) and prevalence of chronic liver disease: A meta-analysis Alessandro Mantovani, Giorgia Beatrice, Andrea Dalbeni
75 [GO] 2020―Apr―05 Let’s not forget our COVID-19-free cirrhotic patients! Mauro Viganò, Marco Carbone
76 [GO] 2020―Apr―02 Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China Yafei Zhang, Liang Zheng, Lan Liu, Mengya Zhao, Jun Xiao, Qiu Zhao
77 [GO] 2020―Apr―02 Clinical characteristics of Non-ICU hospitalized patients with coronavirus disease 2019 and liver injury:A Retrospective study Hansheng Xie, Jianming Zhao, Ningfang Lian, Su Lin, Qunfang Xie, Huichang Zhuo
78 [GO] 2020―Mrz―14 Liver injury during highly pathogenic human coronavirus infections Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng
 [1] 

78 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec